carisoprodol tablet

1 INDICATIONS AND USAGE Carisoprodol Tablets USP are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol Tablets USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration (2) ]. Carisoprodol Tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. (1) Limitations of Use: Should only be used for acute treatment periods up to two or three weeks (1)

aphena pharma solutions - tennessee, llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] nausea` `[4] fatigue` `[5] diarrhoea` `[6] headache` `[7] pain` `[8] pruritus` `[9] dyspnoea` `[10] treatment failure`

5 years ago

ROUND WHITE 2410 V

16 HOW SUPPLIED/STORAGE AND HANDLING Repackaged by Aphena Pharma Solutions - TN. See Repackaging Information for available configurations. Carisoprodol Tablets USP, 350 mg: white, round, unscored tablets debossed "2410 V" on one side and plain on the reverse side; available as follows: Bottles of 100: NDC 0603-2582-21 Bottles of 500: NDC 0603-2582-28 Bottles of 1000: NDC 0603-2582-32 Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

More pills like ROUND 2410 V